Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=29553146
&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\29553146
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 MNI+Open+Res
2018 ; 2
(ä): 2
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Defining Success in Open Science
#MMPMID29553146
Ali-Khan SE
; Jean A
; MacDonald E
; Gold ER
MNI Open Res
2018[]; 2
(ä): 2
PMID29553146
show ga
Mounting evidence indicates that worldwide, innovation systems are increasing
unsustainable. Equally, concerns about inequities in the science and innovation
process, and in access to its benefits, continue. Against a backdrop of growing
health, economic and scientific challenges global stakeholders are urgently
seeking to spur innovation and maximize the just distribution of benefits for
all. Open Science collaboration (OS) - comprising a variety of approaches to
increase open, public, and rapid mobilization of scientific knowledge - is seen
to be one of the most promising ways forward. Yet, many decision-makers hesitate
to construct policy to support the adoption and implementation of OS without
access to substantive, clear and reliable evidence. In October 2017,
international thought-leaders gathered at an Open Science Leadership Forum in the
Washington DC offices of the Bill and Melinda Gates Foundation to share their
views on what successful Open Science looks like. Delegates from developed and
developing nations, national governments, science agencies and funding bodies,
philanthropy, researchers, patient organizations and the biotechnology, pharma
and artificial intelligence (AI) industries discussed the outcomes that would
rally them to invest in OS, as well as wider issues of policy and implementation.
This first of two reports, summarizes delegates' views on what they believe OS
will deliver in terms of research, innovation and social impact in the life
sciences. Through open and collaborative process over the next months, we will
translate these success outcomes into a toolkit of quantitative and qualitative
indicators to assess when, where and how open science collaborations best advance
research, innovation and social benefit. Ultimately, this work aims to develop
and openly share tools to allow stakeholders to evaluate and re-invent their
innovation ecosystems, to maximize value for the global public and patients, and
address long-standing questions about the mechanics of innovation.
free
free
free
